Literature DB >> 31245124

Cell therapy for acute respiratory distress syndrome patients: the START study.

Fernanda Ferreira Cruz1,2, Patricia Rieken Macedo Rocco1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31245124      PMCID： PMC6560575          DOI： 10.21037/jtd.2019.04.22

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

Authors:  Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells.

Authors:  Weiquan Zhu; Jinghai Chen; Xiangfeng Cong; Shengshou Hu; Xi Chen
Journal:  Stem Cells       Date:  2005-10-27       Impact factor: 6.277

3.  Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice.

Authors:  Fernanda F Cruz; Zachary D Borg; Meagan Goodwin; Dino Sokocevic; Darcy Wagner; David H McKenna; Patricia R M Rocco; Daniel J Weiss
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

4.  Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

Authors:  Jennifer G Wilson; Kathleen D Liu; Hanjing Zhuo; Lizette Caballero; Melanie McMillan; Xiaohui Fang; Katherine Cosgrove; Rosemary Vojnik; Carolyn S Calfee; Jae-Woo Lee; Angela J Rogers; Joseph Levitt; Jeanine Wiener-Kronish; Ednan K Bajwa; Andrew Leavitt; David McKenna; B Taylor Thompson; Michael A Matthay
Journal:  Lancet Respir Med       Date:  2014-12-17       Impact factor: 30.700

Review 5.  Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.

Authors:  James Walter; Lorraine B Ware; Michael A Matthay
Journal:  Lancet Respir Med       Date:  2014-10-28       Impact factor: 30.700

6.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.

Authors:  Moïra François; Ian B Copland; Shala Yuan; Raphaëlle Romieu-Mourez; Edmund K Waller; Jacques Galipeau
Journal:  Cytotherapy       Date:  2011-10-27       Impact factor: 5.414

7.  Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.

Authors:  Guoping Zheng; Lanfang Huang; Haijiang Tong; Qiang Shu; Yaoqin Hu; Menghua Ge; Keqin Deng; Liuya Zhang; Bin Zou; Baoli Cheng; Jianguo Xu
Journal:  Respir Res       Date:  2014-04-04

8.  In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Authors:  Oscar E Simonson; Dimitrios Mougiakakos; Nina Heldring; Giulio Bassi; Henrik J Johansson; Magnus Dalén; Regina Jitschin; Sergey Rodin; Matthias Corbascio; Samir El Andaloussi; Oscar P B Wiklander; Joel Z Nordin; Johan Skog; Charlotte Romain; Tina Koestler; Laila Hellgren-Johansson; Petter Schiller; Per-Olof Joachimsson; Hans Hägglund; Mattias Mattsson; Janne Lehtiö; Omid R Faridani; Rickard Sandberg; Olle Korsgren; Mauro Krampera; Daniel J Weiss; Karl-Henrik Grinnemo; Katarina Le Blanc
Journal:  Stem Cells Transl Med       Date:  2016-06       Impact factor: 6.940

9.  Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy.

Authors:  Oliver W Gramlich; Anthony J Burand; Alex J Brown; Riley J Deutsch; Markus H Kuehn; James A Ankrum
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

10.  Autophagy promotes apoptosis of mesenchymal stem cells under inflammatory microenvironment.

Authors:  Shipeng Dang; Zhi-Ming Yu; Chang-Ying Zhang; Jie Zheng; Ku-Lin Li; Ying Wu; Ling-Ling Qian; Zhen-Yu Yang; Xiao-Rong Li; Yanyun Zhang; Ru-Xing Wang
Journal:  Stem Cell Res Ther       Date:  2015-12-15       Impact factor: 6.832
View more
  6 in total

1.  Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019.

Authors:  Ravit Barkama; Ami Mayo; Alona Paz; Anna Solopov; Tal Mann; Zahava Vadasz; Tal Appel; Racheli Ofir; Liran Shani; Michal Sheleg; Hoshea Allen; Rony Shaked Nitzan; Nurit Tsarfaty; Hadar Gilad; Thomas Birch; Erez Kachel; Petra Reinke; Hans-Dieter Volk; Ronen Zalts; Ayelet Raz Pasteur
Journal:  Crit Care Explor       Date:  2020-09-15

2.  Short treatment of peripheral blood cells product with Fas ligand using closed automated cell processing system significantly reduces immune cell reactivity of the graft in vitro and in vivo.

Authors:  Galina Rodionov; Amnon Peled; Shai Yarkoni; Amos Ofer; Michal Rosenzwaig; Michal Schrift Tzadok; Moran Kvint; Elazar Gevir; Elina Zorde-Khvalevsky
Journal:  Bone Marrow Transplant       Date:  2022-05-10       Impact factor: 5.174

Review 3.  Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics.

Authors:  Chasen Cottle; Amanda Paige Porter; Ariel Lipat; Caitlin Turner-Lyles; Jimmy Nguyen; Guido Moll; Raghavan Chinnadurai
Journal:  Curr Stem Cell Rep       Date:  2022-04-27

4.  MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.

Authors:  Guido Moll; Norman Drzeniek; Julian Kamhieh-Milz; Sven Geissler; Hans-Dieter Volk; Petra Reinke
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

Review 5.  The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.

Authors:  Maria Kavianpour; Mahshid Saleh; Javad Verdi
Journal:  Stem Cell Res Ther       Date:  2020-09-18       Impact factor: 6.832

6.  Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.

Authors:  Olle Ringdén; Guido Moll; Britt Gustafsson; Behnam Sadeghi
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.